N(ε)(carboxymethyl)lysin and the AGE receptor RAGE colocalize in age- related macular degeneration

Investigative Ophthalmology and Visual Science

Volumn 40, Issue 8, 1999, Pages 1855-1859

  Hammes, Hans Peter ^a   Hoerauf, Hans ^a   Alt, Alex ^a   Schleicher, Erwin ^a   Clausen, Jes Thorn ^a   Bretzel, Reinhard G ^a   Laqua, Horst ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

LYSINE DERIVATIVE; ADVANCED GLYCATION END PRODUCT; ADVANCED GLYCOSYLATION END PRODUCT RECEPTOR; ADVANCED GLYCOSYLATION END-PRODUCT RECEPTOR; CD68 ANTIGEN, HUMAN; DIFFERENTIATION ANTIGEN; DRUG DERIVATIVE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IMMUNOGLOBULIN RECEPTOR; LEUKOCYTE ANTIGEN; LYSINE; MEMBRANE PROTEIN; N(6) CARBOXYMETHYLLYSINE; N(6)-CARBOXYMETHYLLYSINE;

ADOLESCENT; AGED; ANIMAL CELL; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GLYCATION; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RECEPTOR BINDING; RETINA FOVEA; RETINA MACULA AGE RELATED DEGENERATION; SUBRETINAL NEOVASCULARIZATION; ADULT; ENZYME IMMUNOASSAY; EPIRETINAL MEMBRANE; METABOLISM; RETINA MACULA DEGENERATION; RETINA NEOVASCULARIZATION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; EPIRETINAL MEMBRANE; FEMALE; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; IMMUNOENZYME TECHNIQUES; LYSINE; MACULAR DEGENERATION; MALE; MEMBRANE PROTEINS; NF-KAPPA B; RECEPTORS, IMMUNOLOGIC; RETINAL NEOVASCULARIZATION;

EID: 0032587144     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Klein R, Klein BEK, Linton KLP. Prevalence of age-related maculopathy. The Beaver Dam Eye Study. Ophthalmology. 1992;99: 933-943.
2. Bird AC, Bressler NM, Bressler SB, et al. An international classification and grading system for age-related maculopathy and age-related macular degeneration. Surv Ophthalmol. 1995;39:367-374.
3. Baynes JW, Thorpe SR. Perspectives in diabetes. Role of oxidative stress in diabetic complications. A new perspective on an old paradigm. Diabetes. 1999;48:1-9.
4. e-(carboxymethyl)lysine protein adduct is a major immunological epitope in proteins modified with advanced glycation end products of the Maillard reaction. Biochemistry. 1996;35:8075-8083.
5. e-(carboxymethyl)lysine in Human Tissues in Diabetes and Aging. J Clin Invest. 1997;99:457-468.
6. Schmidt AM, Vianna M, Gerlach M, et al. Isolation and characterization of two binding proteins for advanced glycosylation end products from bovine lung which are present on the endothelial cell surface. J Biol Chem. 1992;267:14987-14997.
7. Fu C, Pischetsrieder M, Hofmann M, Yan SF, Stern D, Schmidt AM. Carboxymethyl-lysine advanced glycation endproduct modifications of proteins are ligands for RAGE that activate cell signalling pathways (abstract). Circulation. 1998;98:1651.
8. Li J, Schmidt AM. Characterization and functional analysis of the promoter of RAGE, the receptor for advanced glycation end products. J Biol Chem. 1997;272:16498-16506.
9. Frank RN, Amin RH, Eliott D, Puklin JE, Abrams GW. Basic fibroblast growth factor and vascular endothelial growth factor are present in epiretinal and choroidal neovascular membranes. Am J Ophthalmol. 1996;122:393-403.
10. Pe'er J, Shweiki D, Itin A, Hemo I, Gnessin H, Keshet E. Hypoxia-induced expression of vascular endothelial growth factor by retinal cells is a common factor in neovascularizing ocular diseases. Lab Invest. 1995;72:638-645.
11. Kuroki M, Voest EE, Amano S, et al. Reactive oxygen intermediates increase vascular endothelial growth factor expression in vitro and in vivo. J Clin Invest. 1996;98:1667-1675.
12. Lu M, Kuroki M, Amano S, et al. Advanced glycation end products increase retinal vascular endothelial growth factor expression. J Clin Invest. 1998;101:1219-1224.
13. Ishibashi T, Murata T, Hangai M, et al. Advanced glycation end products in age-related macular degeneration. Arch Ophthalmol. 1998;116:1629-32.